Table 1.
Subject demographics
| Characteristic | Fluvoxamine cohort (n = 12) | Fluconazole cohort (n = 12) | Rifampin study (n = 12) | Probenecid study (n = 12) |
|---|---|---|---|---|
| Sex, n (%) | ||||
| Male | 10 (83.3) | 12 (100.0) | 10 (83.3) | 7 (58.3) |
| Female | 2 (16.7) | 0 | 2 (16.7) | 5 (41.7) |
| Age, years | ||||
| Median (range) | 34.5 (22.0, 49.0) | 29.0 (23.0, 49.0) | 36.5 (24.0, 54.0) | 34.5 (27.0, 56.0) |
| Mean (standard deviation) | 34.3 (10.4) | 32.4 (9.4) | 37.6 (9.68) | 38.3 (9.3) |
| Race, n (%) | ||||
| White | 10 (83.3) | 10 (83.3) | 8 (66.7) | 6 (50.0) |
| Black or African American | 1 (8.3) | 1 (8.3) | 2 (16.7) | 6 (50.0) |
| Asian | 0 | 0 | 2 (16.7) | 0 |
| Native Hawaiian or other Pacific Islander | 0 | 1 (8.3) | 0 | 0 |
| Other | 1 (8.3) | 0 | 0 | 0 |
| Ethnicity, n (%) | ||||
| Hispanic or Latino | 3 (25.0) | 1 (8.3) | 0 | 5 (41.7) |
| Not Hispanic or Latino | 9 (75.0) | 11 (91.7) | 12 (100.0) | 7 (58.3) |
| Body mass index, kg/m2 | ||||
| Mean (standard deviation) | 24.4 (3.2) | 25.3 (2.5) | 23.9 (1.9) | 27.2 (2.7) |